Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	SGSM1 SIPA1L3 AGAP11 TBC1D13 ARFGAP2 ARAP3 SRGAP3 SRGAP1	1.67e-04	279	111	8	GO:0005096
GeneOntologyMolecularFunction	small GTPase binding	SGSM1 DOCK11 PEX5L TBC1D13 SRGAP1 RAB3IP MLPH PKN3	4.30e-04	321	111	8	GO:0031267
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	SGSM1 DOCK11 SIPA1L3 AGAP11 TBC1D13 ARFGAP2 ARAP3 SRGAP3 SRGAP1 RAB3IP	5.31e-04	507	111	10	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	SGSM1 DOCK11 SIPA1L3 AGAP11 TBC1D13 ARFGAP2 ARAP3 SRGAP3 SRGAP1 RAB3IP	5.31e-04	507	111	10	GO:0030695
Domain	Guanylate_kinase_CS	MAGI1 MAGI3 DLG1	1.05e-04	16	110	3	IPR020590
Domain	FCH	FCHO1 SRGAP3 SRGAP1	2.82e-04	22	110	3	PF00611
Domain	FCH	FCHO1 SRGAP3 SRGAP1	2.82e-04	22	110	3	SM00055
Domain	FCH_dom	FCHO1 SRGAP3 SRGAP1	3.23e-04	23	110	3	IPR001060
Domain	GUANYLATE_KINASE_2	MAGI1 MAGI3 DLG1	3.23e-04	23	110	3	PS50052
Domain	GUANYLATE_KINASE_1	MAGI1 MAGI3 DLG1	3.23e-04	23	110	3	PS00856
Domain	F_BAR	FCHO1 SRGAP3 SRGAP1	4.16e-04	25	110	3	IPR031160
Domain	F_BAR	FCHO1 SRGAP3 SRGAP1	4.16e-04	25	110	3	PS51741
Domain	Guanylate_kin	MAGI1 MAGI3 DLG1	4.68e-04	26	110	3	PF00625
Domain	GK/Ca_channel_bsu	MAGI1 MAGI3 DLG1	4.68e-04	26	110	3	IPR008145
Domain	Guanylate_kin-like_dom	MAGI1 MAGI3 DLG1	4.68e-04	26	110	3	IPR008144
Domain	GuKc	MAGI1 MAGI3 DLG1	4.68e-04	26	110	3	SM00072
Domain	ArfGap	AGAP11 ARFGAP2 ARAP3	6.50e-04	29	110	3	SM00105
Domain	ARFGAP	AGAP11 ARFGAP2 ARAP3	6.50e-04	29	110	3	PS50115
Domain	ArfGap	AGAP11 ARFGAP2 ARAP3	6.50e-04	29	110	3	PF01412
Domain	ArfGAP	AGAP11 ARFGAP2 ARAP3	6.50e-04	29	110	3	IPR001164
Domain	FERM_N	MYO7A PTPN13 FRMD6	9.54e-04	33	110	3	IPR018979
Domain	FERM_N	MYO7A PTPN13 FRMD6	9.54e-04	33	110	3	PF09379
Domain	PDZ	MAGI1 SIPA1L3 MAGI3 PTPN13 DLG1	1.48e-03	141	110	5	PF00595
Domain	PDZ	MAGI1 SIPA1L3 MAGI3 PTPN13 DLG1	1.83e-03	148	110	5	SM00228
Domain	-	MAGI1 SIPA1L3 MAGI3 PTPN13 DLG1	1.95e-03	150	110	5	2.30.42.10
Domain	PDZ	MAGI1 SIPA1L3 MAGI3 PTPN13 DLG1	2.00e-03	151	110	5	PS50106
Domain	PDZ	MAGI1 SIPA1L3 MAGI3 PTPN13 DLG1	2.06e-03	152	110	5	IPR001478
Domain	-	SP100 SKIL	2.18e-03	12	110	2	3.10.390.10
Domain	SAND_dom-like	SP100 SKIL	2.18e-03	12	110	2	IPR010919
Domain	UBA	UBAP1 LATS1 MARK2	2.21e-03	44	110	3	IPR015940
Domain	FERM_M	MYO7A PTPN13 FRMD6	2.51e-03	46	110	3	PF00373
Domain	UBA	UBAP1 LATS1 MARK2	2.67e-03	47	110	3	PS50030
Domain	-	MYO7A PTPN13 FRMD6	3.01e-03	49	110	3	1.20.80.10
Domain	FERM_central	MYO7A PTPN13 FRMD6	3.01e-03	49	110	3	IPR019748
Domain	FERM_domain	MYO7A PTPN13 FRMD6	3.01e-03	49	110	3	IPR000299
Domain	FERM/acyl-CoA-bd_prot_3-hlx	MYO7A PTPN13 FRMD6	3.19e-03	50	110	3	IPR014352
Domain	FERM_1	MYO7A PTPN13 FRMD6	3.19e-03	50	110	3	PS00660
Domain	FERM_2	MYO7A PTPN13 FRMD6	3.19e-03	50	110	3	PS00661
Domain	FERM_3	MYO7A PTPN13 FRMD6	3.19e-03	50	110	3	PS50057
Domain	Band_41_domain	MYO7A PTPN13 FRMD6	3.19e-03	50	110	3	IPR019749
Domain	B41	MYO7A PTPN13 FRMD6	3.19e-03	50	110	3	SM00295
Domain	PH_dom-like	MYO7A DOCK11 AGAP11 PTPN13 ARAP3 FRMD6 NBEAL2 OSBPL6	3.71e-03	426	110	8	IPR011993
Domain	RhoGAP	ARAP3 SRGAP3 SRGAP1	5.84e-03	62	110	3	SM00324
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 DOCK11 IFT74 SIPA1L3 CKAP5 MAGI3 CEP170 ARFGAP2 PTPN13 LATS1 FRMD6 SRGAP1 OSBPL6 KMT2A FAM53B LIMCH1 CRYBG3 MARK2 KIF13A PC PLK4	4.99e-13	861	112	21	36931259
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	CASP8AP2 ARID4B CKAP5 SRPRA NUP214 SIN3A MED1 SKIL JMJD1C KNOP1 ACSL3 RRP9 KMT2A NKTR PC SPTY2D1 HCFC1 LRIF1 TOP3A SON	5.62e-09	1294	112	20	30804502
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAGI1 CKAP5 ZDHHC5 MAGI3 SRPRA NUP214 JMJD1C CEP170 ARFGAP2 PTPN13 LATS1 DLG1 CRYBG3 MARK2 HCFC1	9.34e-09	708	112	15	39231216
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MAGI1 SPAG1 MYO7A IFT74 PCARE MED1 MMADHC DARS2 CEP170 ACSL3 PTPN13 GLI3 RAB3IP OSBPL6 FAM53B NKTR MARK2 PKN3 WDTC1	4.43e-08	1321	112	19	27173435
Pubmed	Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling.	MAGI1 MAGI3 PTPN13 DLG1	7.12e-08	13	112	4	23576434
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	COL5A2 NRIP1 COL6A6 MYO7A DOCK11 SRPRA NUP214 NBEAL2 KMT2A LIMCH1 MARK2 HCFC1	7.71e-08	497	112	12	36774506
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MAGI1 MAGI3 AGAP11 ACSL3 PTPN13 SRGAP3 OSBPL6 PRICKLE2 DLG1 MARK2 PC	1.56e-07	430	112	11	32581705
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SRPRA SIN3A CWC22 JMJD1C LPIN1 ARFGAP2 ARAP3 KMT2A DLG1 CRYBG3 MARK2 HCFC1 TOP3A	1.88e-07	650	112	13	38777146
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAGI1 SPAG1 SIPA1L3 CKAP5 ZDHHC5 MAGI3 NUP214 ARFGAP2 DLG1 LIMCH1 MARK2 HCFC1	3.04e-07	565	112	12	25468996
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ARID4B SIN3A MED1 CDCA8 JMJD1C KNOP1 TRMT6 KMT2A HCFC1 LRIF1 AFF4 NPAT	6.60e-07	608	112	12	36089195
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	REEP1 ETFA CKAP5 SRPRA CEP170 GRAMD1B ACSL3 ARFGAP2 GPR158 SRGAP3 PRICKLE2 DLG1 CRYBG3 CTNND2 PC FAM131B	7.87e-07	1139	112	16	36417873
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	CASP8AP2 NRIP1 IFT74 CKAP5 NUP214 JMJD1C PTPN13 CRYBG3 PC NPAT	1.07e-06	418	112	10	34709266
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ARID4B CKAP5 SIN3A MED1 CDCA8 KNOP1 CEP170 C18orf21 RRP9 MCM9 MARK2 SPTY2D1 SON	1.08e-06	759	112	13	35915203
Pubmed	E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.	SIN3A KMT2A HCFC1	1.13e-06	7	112	3	17612494
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ARID4B CKAP5 NUP214 SIN3A MED1 ACSL3 LATS1 KMT2A PACS2 DLG1 LIMCH1 MARK2 SON	1.34e-06	774	112	13	15302935
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	MAGI1 DOCK11 MAGI3 SRPRA NUP214 KNOP1 CEP170 ARAP3 SRGAP3 SRGAP1 KMT2A DLG1 NKTR PKN3	1.54e-06	916	112	14	32203420
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	ARID4B NUP214 SIN3A KMT2A SON NPAT	1.59e-06	110	112	6	26841866
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	IFT74 SIN3A MED1 JMJD1C CEP170 PTPN13 LATS1 KMT2A DLG1 PC HCFC1	1.71e-06	549	112	11	38280479
Pubmed	Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins.	MAGI1 MAGI3 DLG1	1.80e-06	8	112	3	16316992
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	COL5A2 SIPA1L3 ETFA SRPRA MED1 KNOP1 CEP170 TRMT6 KMT2A NKTR LIMCH1 MARK2 PC SPTY2D1 HCFC1 AFF4 SON	1.89e-06	1371	112	17	36244648
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ETFA CKAP5 NUP214 SIN3A MED1 KNOP1 CEP170 PTPN13 KMT2A PC HCFC1 PKN3 AFF4 SON	1.93e-06	934	112	14	33916271
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ARID4B NUP214 MED1 CWC22 CDCA8 JMJD1C KNOP1 CEP170 KMT2A PC HCFC1 AFF4 SON NPAT	2.47e-06	954	112	14	36373674
Pubmed	Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.	SIN3A KMT2A HCFC1	2.69e-06	9	112	3	15199122
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SIPA1L3 CKAP5 ZDHHC5 FCHO1 JMJD1C CEP170 MTBP CTNND2 SON	2.72e-06	361	112	9	26167880
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 DOCK11 SIPA1L3 HECTD4 CKAP5 PEX5L CEP170 GPR158 SRGAP3 RAB3IP DLG1 LIMCH1 CTNND2 AFF4	2.75e-06	963	112	14	28671696
Pubmed	A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.	SIN3A KMT2A AFF4	3.84e-06	10	112	3	20153263
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	ETFA ZDHHC5 NUP214 CEP170 ACSL3 PTPN13 LATS1 RRP9 LIMCH1 MARK2 SPTY2D1 WDTC1	6.04e-06	754	112	12	33060197
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SIPA1L3 CKAP5 SRPRA MED1 KNOP1 PTPN13 C18orf21 PPP3CC RRP9 KMT2A DLG1 LIMCH1 MARK2 CTNND2 SPTY2D1 AFF4 SON	6.10e-06	1497	112	17	31527615
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ZSWIM8 CKAP5 SIN3A MED1 RAB3IP KMT2A SPTY2D1 HCFC1 SON	7.74e-06	411	112	9	35182466
Pubmed	MAGI-1: a widely expressed, alternatively spliced tight junction protein.	MAGI1 MAGI3	1.03e-05	2	112	2	11969287
Pubmed	Willin, an upstream component of the hippo signaling pathway, orchestrates mammalian peripheral nerve fibroblasts.	LATS1 FRMD6	1.03e-05	2	112	2	23593160
Pubmed	MARK2 phosphorylates KIF13A at a 14-3-3 binding site to polarize vesicular transport of transferrin receptor within dendrites.	MARK2 KIF13A	1.03e-05	2	112	2	38709923
Pubmed	Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.	MAGI1 DLG1	1.03e-05	2	112	2	17267502
Pubmed	Role of the HCF-1 basic region in sustaining cell proliferation.	SIN3A HCFC1	1.03e-05	2	112	2	20126307
Pubmed	Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.	MAGI1 DLG1	1.03e-05	2	112	2	12444549
Pubmed	Slit-Robo GTPase-activating proteins are differentially expressed in murine dorsal root ganglia: modulation by peripheral nerve injury.	SRGAP3 SRGAP1	1.03e-05	2	112	2	22271578
Pubmed	MAGIs regulate aPKC to enable balanced distribution of intercellular tension for epithelial sheet homeostasis.	MAGI1 MAGI3	1.03e-05	2	112	2	33712709
Pubmed	Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis.	ARID4B SIN3A	1.03e-05	2	112	2	22693453
Pubmed	Mutational analysis of FLASH and PTPN13 genes in colorectal carcinomas.	CASP8AP2 PTPN13	1.03e-05	2	112	2	18038312
Pubmed	Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.	NRIP1 MED1 JMJD1C	1.15e-05	14	112	3	11500849
Pubmed	Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density.	MAGI1 MAGI3 DLG1	1.44e-05	15	112	3	23782696
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	MAGI1 DOCK11 SIPA1L3 SRPRA CEP170 ACSL3 PTPN13 LATS1 MARK2	1.48e-05	446	112	9	24255178
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NRIP1 ZSWIM8 IFT74 SIPA1L3 HECTD4 CKAP5 MAGI3 CLIC4 SKIL PTPN13 DLG1 CTNND2 PC AFF4 NR1D2	1.65e-05	1285	112	15	35914814
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	CKAP5 NUP214 JMJD1C CEP170 DLG1 LIMCH1 HCFC1	2.02e-05	256	112	7	33397691
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	SIPA1L3 ZDHHC5 UBAP1 CLIC4 SRPRA NUP214 CWC22 KNOP1 ARFGAP2 PTPN13 LATS1 MARK2 SPTY2D1	2.24e-05	1007	112	13	34597346
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 NRIP1 SGSM1 SIPA1L3 HECTD4 MAGI3 JMJD1C CEP170 USF3 PTPN13 GPR158 RAB3IP DLG1 LIMCH1 MLPH AFF4	2.32e-05	1489	112	16	28611215
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	REEP1 MFSD9 UBAP1 SRPRA NUP214 JMJD1C CEP170 KANK1 DLG1 HCFC1 PKN3	2.58e-05	733	112	11	34672954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SGSM1 MYO7A DOCK11 CKAP5 MAGI3 PCARE SRPRA DARS2 TRMT6 SRGAP3 PRICKLE2	2.68e-05	736	112	11	29676528
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	SIN3A MED1 SKIL JMJD1C KMT2A HCFC1 AFF4	2.71e-05	268	112	7	33640491
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	SP100 CDCA8 JMJD1C KMT2A TDP1 TOP3A	2.95e-05	183	112	6	36129980
Pubmed	SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.	KMT2A SON	3.08e-05	3	112	2	26990989
Pubmed	E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.	KMT2A HCFC1	3.08e-05	3	112	2	19763085
Pubmed	Premature polyadenylation of MAGI3 is associated with diminished N6-methyladenosine in its large internal exon.	MAGI3 LATS1	3.08e-05	3	112	2	29362392
Pubmed	HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.	MAGI1 DLG1	3.08e-05	3	112	2	11571640
Pubmed	Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.	MAGI1 DLG1	3.08e-05	3	112	2	21489588
Pubmed	Structural Analysis of the SANT/Myb Domain of FLASH and YARP Proteins and Their Complex with the C-Terminal Fragment of NPAT by NMR Spectroscopy and Computer Simulations.	CASP8AP2 NPAT	3.08e-05	3	112	2	32722282
Pubmed	Dynamic expression of the Slit-Robo GTPase activating protein genes during development of the murine nervous system.	SRGAP3 SRGAP1	3.08e-05	3	112	2	19137586
Pubmed	FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies.	CASP8AP2 SP100	3.08e-05	3	112	2	17245429
Pubmed	FLASH and NPAT positive but not Coilin positive Cajal Bodies correlate with cell ploidy.	CASP8AP2 NPAT	3.08e-05	3	112	2	18677100
Pubmed	The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection.	KMT2A HCFC1	3.08e-05	3	112	2	17578910
Pubmed	AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).	KMT2A AFF4	3.08e-05	3	112	2	10588740
Pubmed	FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription.	CASP8AP2 NPAT	3.08e-05	3	112	2	21725362
Pubmed	A conserved interaction that is essential for the biogenesis of histone locus bodies.	CASP8AP2 NPAT	3.08e-05	3	112	2	25339177
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	IFT74 CLIC4 SRPRA NUP214 DARS2 CEP170 ACSL3 SRGAP3 HCFC1	3.51e-05	498	112	9	36634849
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	CKAP5 CEP170 PTPN13 MARK2	3.53e-05	57	112	4	29089450
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	ZDHHC5 SRPRA NUP214 JMJD1C GRAMD1B ACSL3	3.74e-05	191	112	6	31177093
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NRIP1 MED1 JMJD1C	4.14e-05	21	112	3	19596656
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ZDHHC5 SRPRA DMXL1 KNOP1 ARFGAP2 PTPN13 FRMD6 GLI3 DLG1 PC SPTY2D1	4.37e-05	777	112	11	35844135
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	COL5A2 DOCK11 CKAP5 SRPRA CWC22 LATS1 C18orf21 HCFC1	4.71e-05	399	112	8	37536630
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	IFT74 NUP214 JMJD1C HCFC1 NR1D2	5.06e-05	123	112	5	26912792
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CKAP5 NUP214 GRAMD1B KANK1 SRGAP3 PACS2 LIMCH1 SON	5.41e-05	407	112	8	12693553
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	MAGI1 SIPA1L3 ZDHHC5 KANK1 FRMD6	5.46e-05	125	112	5	29467281
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYO7A SIPA1L3 CKAP5 CEP170 GRAMD1B SRGAP3 OSBPL6 PRICKLE2 KMT2A PACS2 DLG1 LIMCH1 MARK2 CTNND2 PC	5.65e-05	1431	112	15	37142655
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	SRPRA CWC22 KNOP1 ARFGAP2 MARK2 SPTY2D1 HCFC1 SON	5.70e-05	410	112	8	26949251
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	MYO7A CKAP5 GRAMD1B DLG1 CTNND2	6.11e-05	128	112	5	30995482
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	MAGI1 MAGI3 LPIN1 PTPN13 HCFC1	6.11e-05	128	112	5	25332235
Pubmed	Interaction of the RhoA exchange factor Net1 with discs large homolog 1 protects it from proteasome-mediated degradation and potentiates Net1 activity.	MAGI1 DLG1	6.14e-05	4	112	2	19586902
Pubmed	Palmitoylation of δ-catenin by DHHC5 mediates activity-induced synapse plasticity.	ZDHHC5 CTNND2	6.14e-05	4	112	2	24562000
Pubmed	Restoration of the Mendelian transmission ratio by a deletion in the mouse chromosome 1 HSR.	SP100 SAG	6.14e-05	4	112	2	9717434
Pubmed	SET-NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene.	NUP214 KMT2A	6.14e-05	4	112	2	34320268
Pubmed	A role for myosin VI in postsynaptic structure and glutamate receptor endocytosis.	MYO7A DLG1	6.14e-05	4	112	2	15657400
Pubmed	Association of the kinesin superfamily motor protein KIF1Balpha with postsynaptic density-95 (PSD-95), synapse-associated protein-97, and synaptic scaffolding molecule PSD-95/discs large/zona occludens-1 proteins.	MAGI1 DLG1	6.14e-05	4	112	2	12097473
Pubmed	Identification of 14-3-3epsilon substrates from embryonic murine brain.	CEP170 SRGAP3 RAB3IP PACS2 MARK2	7.07e-05	132	112	5	16944949
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	SIN3A MED1 JMJD1C KMT2A HCFC1	7.59e-05	134	112	5	25452129
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CLIC4 SRPRA SIN3A CWC22 JMJD1C DARS2 RRP9 PC SPTY2D1 HCFC1 AFF4 SON	8.52e-05	989	112	12	36424410
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	NRIP1 ETFA SRPRA NUP214 CWC22 DARS2 KNOP1 RRP9 KMT2A NKTR PC HCFC1 LRIF1 SON	8.86e-05	1318	112	14	30463901
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	SIPA1L3 CKAP5 NUP214 CWC22 CDCA8 CEP170 KANK1 RRP9 MARK2 PLK4 HCFC1 TOP3A WDTC1	9.07e-05	1155	112	13	20360068
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	CKAP5 SRPRA NUP214 CEP170 GRAMD1B ACSL3 ARFGAP2 LIMCH1 HCFC1	9.61e-05	568	112	9	37774976
Pubmed	Genomic analysis of mouse retinal development.	ZSWIM8 SKIL PEX5L CDCA8 GRAMD1B ARFGAP2 SAG SRGAP3 MCM9 KMT2A FAM53B IMPG2	1.00e-04	1006	112	12	15226823
Pubmed	Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling.	IFT74 GLI3	1.02e-04	5	112	2	33241915
Pubmed	Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways.	KMT2A HCFC1	1.02e-04	5	112	2	21670200
Pubmed	Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion.	SIN3A SKIL	1.02e-04	5	112	2	9988677
Pubmed	Gene repressive activity of RIP140 through direct interaction with CDK8.	NRIP1 MED1	1.02e-04	5	112	2	21868449
Pubmed	Slac2-c (synaptotagmin-like protein homologue lacking C2 domains-c), a novel linker protein that interacts with Rab27, myosin Va/VIIa, and actin.	MYO7A MLPH	1.02e-04	5	112	2	12221080
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	SPAG1 SIPA1L3 ZDHHC5 MAGI3 TRMT6 PTPN13 C18orf21 DLG1 KIF13A MLPH	1.14e-04	719	112	10	35337019
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	JMJD1C KNOP1 HCFC1 AFF4 SON	1.21e-04	148	112	5	32538781
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	SIN3A MED1 JMJD1C DARS2 KMT2A HCFC1 AFF4	1.23e-04	341	112	7	32971831
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ZDHHC5 PEX5L SRGAP3 RAB3IP PRICKLE2 MARK2 CTNND2	1.37e-04	347	112	7	17114649
Pubmed	The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator.	MED1 HCFC1	1.53e-04	6	112	2	14983011
Pubmed	Delta proteins and MAGI proteins: an interaction of Notch ligands with intracellular scaffolding molecules and its significance for zebrafish development.	MAGI1 MAGI3	1.53e-04	6	112	2	15509766
Interaction	YWHAH interactions	MAGI1 NRIP1 DOCK11 IFT74 SIPA1L3 HECTD4 CKAP5 MAGI3 MED1 CWC22 CEP170 ARFGAP2 KANK1 PTPN13 LATS1 FRMD6 SRGAP1 OSBPL6 KMT2A PACS2 MTBP FAM53B NKTR LIMCH1 CRYBG3 MARK2 PLK4	6.88e-12	1102	104	27	int:YWHAH
Interaction	YWHAG interactions	MAGI1 REEP1 DOCK11 SIPA1L3 HECTD4 CKAP5 MAGI3 CWC22 CEP170 LPIN1 KANK1 PTPN13 LATS1 FRMD6 SRGAP1 OSBPL6 KMT2A PACS2 MTBP FAM53B NKTR MARK2 KIF13A PLK4 SON	3.22e-09	1248	104	25	int:YWHAG
Interaction	YWHAZ interactions	REEP1 COL6A6 DOCK11 SIPA1L3 HECTD4 CKAP5 CLIC4 SRPRA CEP170 GRAMD1B KANK1 PTPN13 LATS1 PPP3CC FRMD6 SRGAP3 NBEAL2 SRGAP1 OSBPL6 KMT2A PACS2 MTBP FAM53B MARK2 PLK4	9.81e-09	1319	104	25	int:YWHAZ
Interaction	NUP43 interactions	CASP8AP2 ARID4B IFT74 DDX60 NUP214 CWC22 CDCA8 JMJD1C KNOP1 KMT2A NKTR HCFC1 NR1D2 SON NPAT	7.43e-07	625	104	15	int:NUP43
Interaction	YWHAE interactions	REEP1 DOCK11 SIPA1L3 CKAP5 CLIC4 CEP170 LPIN1 KANK1 PTPN13 LATS1 FRMD6 SRGAP3 SRGAP1 RAB3IP OSBPL6 KMT2A PACS2 MTBP FAM53B MARK2 PLK4	1.45e-06	1256	104	21	int:YWHAE
Interaction	KCNA3 interactions	MAGI1 NRIP1 CKAP5 ZDHHC5 MAGI3 SRPRA NUP214 JMJD1C CEP170 ARFGAP2 PTPN13 LATS1 KMT2A DLG1 CRYBG3 MARK2 HCFC1	2.19e-06	871	104	17	int:KCNA3
Interaction	SFN interactions	MAGI1 DOCK11 SIPA1L3 CEP170 PTPN13 LATS1 FRMD6 RAB3IP KMT2A PACS2 FAM53B CRYBG3 MARK2 KIF13A PLK4	2.62e-06	692	104	15	int:SFN
Interaction	CRHR1 interactions	MAGI1 MAGI3 PTPN13 DLG1	3.74e-06	21	104	4	int:CRHR1
Interaction	YWHAB interactions	MAGI1 DOCK11 SIPA1L3 HECTD4 CEP170 KANK1 PTPN13 LATS1 FRMD6 SRGAP1 OSBPL6 KMT2A PACS2 MTBP FAM53B MARK2 PLK4 SON	4.04e-06	1014	104	18	int:YWHAB
Interaction	CDH1 interactions	MAGI1 SPAG1 MYO7A SIPA1L3 CKAP5 ZDHHC5 MAGI3 NUP214 CDCA8 ARFGAP2 DLG1 LIMCH1 MARK2 CTNND2 HCFC1	9.21e-06	768	104	15	int:CDH1
Interaction	PHF21A interactions	CASP8AP2 IFT74 CKAP5 NUP214 JMJD1C PTPN13 CRYBG3 PC PKN3 NPAT	1.13e-05	343	104	10	int:PHF21A
Interaction	HDAC1 interactions	CASP8AP2 NRIP1 ARID4B IFT74 CKAP5 SRPRA NUP214 SIN3A SKIL JMJD1C PTPN13 GLI3 KMT2A CRYBG3 PC HCFC1 NR1D2 NPAT	1.36e-05	1108	104	18	int:HDAC1
Interaction	YWHAQ interactions	NRIP1 DOCK11 SIPA1L3 HECTD4 MED1 CEP170 KANK1 PTPN13 LATS1 FRMD6 SRGAP1 OSBPL6 KMT2A PACS2 FAM53B MARK2 PC PLK4	1.53e-05	1118	104	18	int:YWHAQ
Interaction	FBXO22 interactions	COL5A2 NRIP1 COL6A6 MYO7A DOCK11 SRPRA NUP214 NBEAL2 KMT2A LIMCH1 MARK2 HCFC1	2.23e-05	540	104	12	int:FBXO22
Interaction	PARD3 interactions	MAGI1 SIPA1L3 ZDHHC5 MAGI3 PEX5L PTPN13 LATS1 DLG1 MARK2	2.41e-05	298	104	9	int:PARD3
Interaction	SIPA1L1 interactions	MAGI1 SIPA1L3 PTPN13 LATS1 RAB3IP OSBPL6 WDTC1	3.33e-05	174	104	7	int:SIPA1L1
Interaction	KLHL7 interactions	NRIP1 CKAP5 GLI3 SRGAP1 PRICKLE2	3.78e-05	73	104	5	int:KLHL7
Interaction	PLCD3 interactions	IFT74 SKIL CWC22 KANK1 OSBPL6 AFF4	3.88e-05	121	104	6	int:PLCD3
Interaction	CBY1 interactions	MAGI1 CEP170 PTPN13 RAB3IP OSBPL6 FAM53B MARK2	4.44e-05	182	104	7	int:CBY1
Interaction	ASF1A interactions	CASP8AP2 CDCA8 ARFGAP2 KMT2A SPTY2D1 HCFC1 LRIF1 NPAT	4.50e-05	249	104	8	int:ASF1A
Interaction	GOLGA1 interactions	IFT74 DMXL1 ARFGAP2 PTPN13 OSBPL6 CRYBG3 TDP1	4.59e-05	183	104	7	int:GOLGA1
Interaction	SH3PXD2A interactions	MAGI1 PTPN13 RAB3IP OSBPL6 MARK2 WDTC1	5.32e-05	128	104	6	int:SH3PXD2A
Interaction	S100A2 interactions	NRIP1 ARID4B CKAP5 CDCA8 PTPN13 LATS1 C18orf21 MTBP CRYBG3 PKN3	5.40e-05	412	104	10	int:S100A2
Interaction	AFDN interactions	MAGI1 SIPA1L3 ZDHHC5 PTPN13 FRMD6 RAB3IP KMT2A DLG1 MARK2	5.71e-05	333	104	9	int:AFDN
Interaction	SRGAP2 interactions	MAGI1 PTPN13 SRGAP3 SRGAP1 RAB3IP OSBPL6 PRICKLE2	7.32e-05	197	104	7	int:SRGAP2
Interaction	MLLT3 interactions	NRIP1 RBM48 KMT2A LRIF1 AFF4	7.85e-05	85	104	5	int:MLLT3
Interaction	SLC6A4 interactions	MAGI1 MAGI3 ACSL3 PTPN13 SRGAP3 OSBPL6 PRICKLE2 DLG1 MARK2 PC	8.80e-05	437	104	10	int:SLC6A4
Interaction	SYNE3 interactions	IFT74 SIPA1L3 SRPRA NUP214 GRAMD1B ACSL3 ARFGAP2 LATS1 GLI3 CRYBG3	1.00e-04	444	104	10	int:SYNE3
Interaction	STX6 interactions	ZDHHC5 SRPRA DMXL1 ARFGAP2 PTPN13 OSBPL6 DLG1 CRYBG3 MARK2 KIF13A	1.08e-04	448	104	10	int:STX6
Interaction	H3-3A interactions	ARID4B CKAP5 SIN3A MED1 CDCA8 JMJD1C KNOP1 TRMT6 KMT2A HCFC1 LRIF1 AFF4 NPAT	1.26e-04	749	104	13	int:H3-3A
Interaction	NUAK1 interactions	ZSWIM8 CKAP5 LATS1 RAB3IP SON	1.40e-04	96	104	5	int:NUAK1
Interaction	NAA40 interactions	ETFA CKAP5 NUP214 SIN3A MED1 KNOP1 CEP170 PTPN13 KMT2A LIMCH1 PC HCFC1 PKN3 AFF4 SON	1.46e-04	978	104	15	int:NAA40
Interaction	TAF9 interactions	SIN3A RBM48 GLI3 KMT2A HCFC1 NR1D2	1.76e-04	159	104	6	int:TAF9
Interaction	PPIA interactions	SP100 DDX60 ETFA CLIC4 MED1 SKIL CDCA8 CEP170 TRMT6 OSBPL6 CRYBG3 HCFC1 PKN3 WDTC1	1.87e-04	888	104	14	int:PPIA
Interaction	EMILIN1 interactions	NUP214 CDCA8 UBOX5 CEP170 LRIF1	1.95e-04	103	104	5	int:EMILIN1
Interaction	ASB7 interactions	CEP170 KMT2A KIF13A NPAT	2.00e-04	56	104	4	int:ASB7
Interaction	RAPGEF2 interactions	MAGI1 MAGI3 TRMT6 PTPN13 SRGAP1	2.13e-04	105	104	5	int:RAPGEF2
Interaction	AMOT interactions	MAGI1 IFT74 SIPA1L3 RBM48 PTPN13 LATS1 DLG1 CRYBG3	2.15e-04	312	104	8	int:AMOT
Interaction	RCOR1 interactions	CASP8AP2 SP100 IFT74 CKAP5 SIN3A JMJD1C PTPN13 PC PKN3 NPAT	2.38e-04	494	104	10	int:RCOR1
Interaction	H3C3 interactions	SIN3A MED1 CDCA8 JMJD1C KNOP1 TRMT6 KMT2A LRIF1 AFF4 NPAT	2.42e-04	495	104	10	int:H3C3
Interaction	H2BC21 interactions	ARID4B IFT74 CDCA8 JMJD1C USF3 OSBPL6 KMT2A MTBP HCFC1 LRIF1 TOP3A WDTC1	2.48e-04	696	104	12	int:H2BC21
Interaction	PHLPP1 interactions	CKAP5 NUP214 JMJD1C CEP170 DLG1 LIMCH1 MARK2 HCFC1	3.32e-04	333	104	8	int:PHLPP1
Interaction	WWTR1 interactions	IFT74 SIN3A JMJD1C CEP170 PTPN13 LATS1 KMT2A DLG1 HCFC1	3.38e-04	422	104	9	int:WWTR1
Interaction	INPP5E interactions	MAGI1 CEP170 PTPN13 OSBPL6	3.56e-04	65	104	4	int:INPP5E
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	FCHO1 SRGAP3 SRGAP1	1.10e-04	23	74	3	1288
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	MAGI1 MAGI3 DLG1	1.60e-04	26	74	3	904
GeneFamily	ArfGAPs	AGAP11 ARFGAP2 ARAP3	3.29e-04	33	74	3	395
GeneFamily	PDZ domain containing	MAGI1 SIPA1L3 MAGI3 PTPN13 DLG1	3.97e-04	152	74	5	1220
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO7A PTPN13 FRMD6	1.12e-03	50	74	3	1293
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	ARID4B DOCK11 DDX60 ETFA SKIL EDN1 ACSL3 PPP3CC FRMD6 LIMCH1 CTNND2 LRIF1 FAM131B	2.05e-07	504	110	13	M2157
Coexpression	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	COL5A2 SPAG1 DOCK11 SKIL EDN1 KANK1 PTPN13 ARAP3 PRICKLE2 LIMCH1 CRYBG3 SPTY2D1	6.36e-06	583	110	12	M17454
Coexpression	GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP	DOCK11 SIPA1L3 NUP214 JMJD1C M1AP CACNA2D4 NR1D2	2.02e-05	197	110	7	M3136
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	NRIP1 ZSWIM8 ARID4B DDX60 CEP170 RBM38 NPAT	2.22e-05	200	110	7	M8030
Coexpression	GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP	NRIP1 DDX60 MED1 LPIN1 FRMD6 SRGAP3 NR1D2	2.22e-05	200	110	7	M4584
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ARID4B MYO7A DOCK11 HECTD4 SRPRA SIN3A MED1 JMJD1C LPIN1 LATS1 PPP3CC SRGAP3 NBEAL2 KMT2A FAM53B RBM38 SON NPAT	4.78e-05	1492	110	18	M40023
Coexpression	FISCHER_DREAM_TARGETS	CASP8AP2 CKAP5 CLIC4 SIN3A CDCA8 DARS2 KNOP1 RRP9 MTBP TDP1 PLK4 HCFC1 TOP3A NPAT	5.51e-05	969	110	14	M149
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	REEP1 COL6A6 MYO7A MAGI3 SIN3A PEX5L LPIN1 ZNF385D GPR158 SRGAP3 SRGAP1 OSBPL6 PRICKLE2 CTNND2 KIF13A	6.00e-05	1106	110	15	M39071
Coexpression	VILLANUEVA_LIVER_CANCER_KRT19_UP	SIPA1L3 CWC22 CDCA8 TRMT6 CTNND2 PLK4	9.81e-05	175	110	6	M336
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	NRIP1 ZDHHC5 UBAP1 USF3 DLG1 CRYBG3 AFF4	1.31e-04	265	110	7	M1684
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	NRIP1 ZDHHC5 UBAP1 USF3 DLG1 CRYBG3 AFF4	1.54e-04	272	110	7	MM1027
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	NRIP1 SIN3A MED1 GRAMD1B USF3 RAB3IP NKTR AFF4 NR1D2	1.77e-04	474	110	9	M40991
Coexpression	GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP	ZSWIM8 SP100 DDX60 JMJD1C SRGAP3 LRIF1	1.92e-04	198	110	6	M8036
Coexpression	GSE16266_CTRL_VS_LPS_STIM_MEF_UP	NRIP1 SKIL CEP170 ARAP3 FAM53B DNASE2	1.92e-04	198	110	6	M7219
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP	SP100 PEX5L UBOX5 LPIN1 NR1D2 SON	1.92e-04	198	110	6	M5580
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN	SKIL CEP170 GRAMD1B LPIN1 KANK1 NKTR	1.92e-04	198	110	6	M3195
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN	SPAG1 CKAP5 CLIC4 PEX5L PLK4 HCFC1	1.98e-04	199	110	6	M8029
Coexpression	GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP	NRIP1 ARID4B PPP3CC RRP9 DLG1 NR1D2	1.98e-04	199	110	6	M324
Coexpression	GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	NRIP1 ARID4B RBM48 MED1 RBM38 NPAT	2.03e-04	200	110	6	M8032
Coexpression	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP	CASP8AP2 DMXL1 KNOP1 ACSL3 KIF13A SON	2.03e-04	200	110	6	M8098
Coexpression	GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	COL5A2 CLIC4 FRMD6 KMT2A PLK4 TOP3A	2.03e-04	200	110	6	M9675
Coexpression	GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	COL5A2 SIN3A MED1 EDN1 M1AP FRMD6	2.03e-04	200	110	6	M6480
Coexpression	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	ETFA FCHO1 DMXL1 SRGAP3 KMT2A FAM131B	2.03e-04	200	110	6	M5192
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	NRIP1 DOCK11 CLIC4 CACNA2D4 RAB3IP RBM38	2.03e-04	200	110	6	M9205
Coexpression	GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP	CLIC4 SIN3A M1AP TBC1D13 RAB3IP NR1D2	2.03e-04	200	110	6	M3925
Coexpression	GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	CASP8AP2 NRIP1 FRMD6 MCM9 PRICKLE2 DLG1	2.03e-04	200	110	6	M8765
Coexpression	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	SPAG1 SGSM1 REEP1 DOCK11 TBC1D13 PTPN13 PRICKLE2 LIMCH1 CTNND2	2.30e-04	491	110	9	M13661
Coexpression	AIZARANI_LIVER_C20_LSECS_3	NRIP1 JMJD1C CEP170 SRGAP1 PRICKLE2 LIMCH1 AFF4	2.52e-04	295	110	7	M39121
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	COL5A2 NRIP1 SP100 CKAP5 MED1 CEP170 ACSL3 PTPN13 DLG1 CRYBG3 SON NPAT	2.56e-04	856	110	12	M4500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	MAGI1 CASP8AP2 SP100 ARID4B REEP1 IFT74 CKAP5 CWC22 KNOP1 TRMT6 USF3 LATS1 SRGAP3 GLI3 SRGAP1 CTNND2 LRIF1	7.79e-06	989	106	17	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	MAGI1 CASP8AP2 ARID4B IFT74 CKAP5 USF3 LATS1 GLI3 SRGAP1	2.62e-05	311	106	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 SIPA1L3 MAGI3 KANK1 PTPN13 PRICKLE2 DLG1 LIMCH1 KIF13A	1.77e-09	198	111	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	CKAP5 MED1 USF3 LATS1 DLG1 CRYBG3 SPTY2D1 SON	3.00e-08	193	111	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SP100 ARID4B DDX60 JMJD1C KMT2A NKTR AFF4 SON	3.95e-08	200	111	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SP100 ARID4B DDX60 SKIL JMJD1C NKTR RBM38	6.41e-07	197	111	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SP100 ARID4B DDX60 SKIL JMJD1C NKTR RBM38	6.63e-07	198	111	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SP100 ARID4B DDX60 SKIL JMJD1C NKTR RBM38	6.63e-07	198	111	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 SIPA1L3 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	6.86e-07	199	111	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	2.95e-06	159	111	6	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	HECTD4 USF3 SRGAP3 SON IMPG2 WDTC1	3.79e-06	166	111	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	343B-Lymphocytic-ILC\|343B / Donor, Lineage, Cell class and subclass (all cells)	SP100 MYO7A TBC1D13 USF3 PPP3CC FAM131B	3.79e-06	166	111	6	a54377c703efff42d2cc1a8fdb610facc58053dd
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	6.63e-06	183	111	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SP100 ARID4B DDX60 SKIL JMJD1C AFF4	6.63e-06	183	111	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	6.84e-06	184	111	6	561592edc3083fad41b91811151b442207c65dd9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	7.05e-06	185	111	6	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CKAP5 CLIC4 LPIN1 MLPH PLK4 IMPG2	7.05e-06	185	111	6	b4af9ae4c358b48357cb135b740266e1652d886a
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	SIPA1L3 HECTD4 KANK1 PRICKLE2 DLG1 CTNND2	7.27e-06	186	111	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	7.27e-06	186	111	6	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SIPA1L3 HECTD4 KANK1 PRICKLE2 DLG1 CTNND2	7.27e-06	186	111	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	7.50e-06	187	111	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	7.50e-06	187	111	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	7.73e-06	188	111	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	7.73e-06	188	111	6	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	343B-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MYO7A TBC1D13 USF3 PPP3CC FAM131B NR1D2	7.97e-06	189	111	6	c26428871dc3261327d89cacaba6e21e004ff1f3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	7.97e-06	189	111	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 REEP1 MAGI3 NBEAL2 LIMCH1 CTNND2	8.21e-06	190	111	6	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	8.46e-06	191	111	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	8.46e-06	191	111	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	8.72e-06	192	111	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID4B MAGI3 ACSL3 DLG1 NKTR AFF4	8.72e-06	192	111	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	8.72e-06	192	111	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	8.72e-06	192	111	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID4B MAGI3 ACSL3 DLG1 NKTR AFF4	8.98e-06	193	111	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	9.25e-06	194	111	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 PRICKLE2 LIMCH1 CTNND2	9.52e-06	195	111	6	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 KMT2A NKTR PC AFF4 SON	9.52e-06	195	111	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	9.52e-06	195	111	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 SIPA1L3 MAGI3 KANK1 DLG1 LIMCH1	9.80e-06	196	111	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL5A2 COL6A6 ZNF385D SRGAP3 GLI3 PRICKLE2	9.80e-06	196	111	6	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL5A2 COL6A6 ZNF385D SRGAP3 GLI3 PRICKLE2	1.04e-05	198	111	6	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	1.07e-05	199	111	6	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1 MLPH	1.07e-05	199	111	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ACSL3 SRGAP3 SRGAP1 LIMCH1 MLPH	1.10e-05	200	111	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SP100 ARID4B KMT2A AFF4 RBM38 SON	1.10e-05	200	111	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 LIMCH1 MLPH	5.52e-05	163	111	5	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 PRICKLE2 LIMCH1	6.02e-05	166	111	5	c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell	Control\|World / group, cell type (main and fine annotations)	MAGI1 MAGI3 KANK1 LIMCH1 MLPH	6.37e-05	168	111	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASP8AP2 SPAG1 PCDHA2 GLI3 LIMCH1	6.55e-05	169	111	5	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 PRICKLE2 LIMCH1	6.73e-05	170	111	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A2 PTPN13 PRICKLE2 CRYBG3 CTNND2	7.52e-05	174	111	5	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	DOCK11 SIPA1L3 ARAP3 OSBPL6 PC	7.72e-05	175	111	5	2812ac2ef41d245db544697fb6da1883361c96e8
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	ZDHHC5 PTPN13 FRMD6 CRYBG3 MARK2	7.72e-05	175	111	5	0cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell	facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 SGSM1 REEP1 MYO7A DLG1	7.93e-05	176	111	5	057d2759fdc67176c25802b57a78064d8cc93205
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 SGSM1 REEP1 MYO7A DLG1	7.93e-05	176	111	5	b81e5d23b31cefc8d374ef403e21acc390c14a80
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 PRICKLE2 LIMCH1	8.37e-05	178	111	5	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SRGAP3 SRGAP1 DLG1 NKTR AFF4	8.59e-05	179	111	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASP8AP2 COL5A2 PCDHA2 EDN1 MLPH	8.82e-05	180	111	5	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEX5L SRGAP3 MTBP MLPH PLK4	8.82e-05	180	111	5	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	MAGI3 KANK1 PTPN13 LIMCH1 MLPH	8.82e-05	180	111	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASP8AP2 COL5A2 PCDHA2 EDN1 MLPH	8.82e-05	180	111	5	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEX5L SRGAP3 MTBP MLPH PLK4	8.82e-05	180	111	5	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEX5L SRGAP3 MTBP MLPH PLK4	8.82e-05	180	111	5	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASP8AP2 COL5A2 PCDHA2 EDN1 MLPH	8.82e-05	180	111	5	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C18orf21 DLG1 LIMCH1 CRYBG3	9.02e-05	94	111	4	d25f096626af873f724a8cd6454ed56e33fd9854
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C18orf21 DLG1 LIMCH1 CRYBG3	9.02e-05	94	111	4	2fb80a08f823295fa4c3e6494bf020e5b4052f0f
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAGI1 SGSM1 REEP1 MYO7A DLG1	9.29e-05	182	111	5	2cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAGI1 SGSM1 REEP1 MYO7A DLG1	9.29e-05	182	111	5	0cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAGI1 SGSM1 REEP1 MYO7A DLG1	9.29e-05	182	111	5	3e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 COL5A2 MAGI3 LIMCH1 MLPH	9.53e-05	183	111	5	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SP100 ARAP3 SRGAP1 PRICKLE2 KIF13A	9.53e-05	183	111	5	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	MAGI3 KANK1 PTPN13 LIMCH1 MLPH	9.78e-05	184	111	5	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 LIMCH1 MLPH	9.78e-05	184	111	5	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKAP5 CDCA8 MLPH PLK4 IMPG2	9.78e-05	184	111	5	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 PRICKLE2 LIMCH1	1.00e-04	185	111	5	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 PRICKLE2 LIMCH1	1.00e-04	185	111	5	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	MAGI1 SIPA1L3 MAGI3 LIMCH1 CTNND2	1.00e-04	185	111	5	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 MAGI3 PTPN13 LIMCH1 MLPH	1.00e-04	185	111	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	MAGI1 MAGI3 EDN1 PTPN13 LIMCH1	1.03e-04	186	111	5	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CASP8AP2 ARID4B MED1 SPTY2D1 NPAT	1.03e-04	186	111	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MAGI3 NBEAL2 LIMCH1 CTNND2	1.05e-04	187	111	5	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1	1.05e-04	187	111	5	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MAGI3 PTPN13 LIMCH1 MLPH	1.05e-04	187	111	5	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL5A2 PTPN13 SRGAP3 GLI3 PRICKLE2	1.05e-04	187	111	5	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGSM1 GRAMD1B ZNF385D KANK1 LIMCH1	1.08e-04	188	111	5	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SGSM1 GRAMD1B ZNF385D KANK1 LIMCH1	1.08e-04	188	111	5	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 COL6A6 PTPN13 SRGAP1 LIMCH1	1.11e-04	189	111	5	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1	1.14e-04	190	111	5	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI3 KANK1 PTPN13 LIMCH1 MLPH	1.14e-04	190	111	5	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SIPA1L3 PTPN13 SRGAP3 NBEAL2	1.16e-04	191	111	5	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPAG1 ARID4B JMJD1C NKTR RBM38	1.16e-04	191	111	5	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	MAGI3 KANK1 PTPN13 LIMCH1 MLPH	1.16e-04	191	111	5	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 LIMCH1 MLPH	1.16e-04	191	111	5	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1	1.16e-04	191	111	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	MAGI1 MAGI3 EDN1 PTPN13 LIMCH1	1.19e-04	192	111	5	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 COL6A6 LPIN1 PTPN13 SRGAP1	1.19e-04	192	111	5	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MAGI3 NBEAL2 LIMCH1 MLPH	1.19e-04	192	111	5	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	MAGI1 KANK1 PTPN13 LIMCH1 MLPH	1.19e-04	192	111	5	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL5A2 PTPN13 FRMD6 SRGAP1 PRICKLE2	1.19e-04	192	111	5	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 COL6A6 ZNF385D FRMD6 GLI3	1.19e-04	192	111	5	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 COL6A6 LPIN1 PTPN13 SRGAP1	1.19e-04	192	111	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MAGI3 KANK1 PTPN13 LIMCH1	1.19e-04	192	111	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
Computational	Genes in the cancer module 206.	REEP1 HECTD4 GRAMD1B LPIN1 SRGAP3 RAB3IP NKTR	5.04e-05	154	68	7	MODULE_206
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	SIPA1L3 UBOX5 KNOP1 TBC1D13 NBEAL2 PACS2 FAM53B TDP1 RBM38	6.07e-07	200	111	9	7261_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NRIP1 SRPRA MED1 KMT2A DLG1 NKTR DNASE2 SON	3.83e-06	187	111	8	4302_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	IFT74 SIPA1L3 MED1 CDCA8 NBEAL2 PLK4 TOP3A WDTC1	4.65e-06	192	111	8	7176_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	SP100 UBAP1 SKIL PPP3CC NBEAL2 MARK2 HCFC1 WDTC1	5.41e-06	196	111	8	1629_DN
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	REEP1 SKIL NBEAL2 KMT2A LIMCH1 HCFC1 TOP3A WDTC1	5.41e-06	196	111	8	2775_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	ZSWIM8 SPAG1 MFSD9 GRAMD1B NBEAL2 MARK2 MLPH WDTC1	5.41e-06	196	111	8	3121_DN
Drug	Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SP100 RBM48 FAM53B LIMCH1 MARK2 CTNND2 HCFC1 DNASE2	5.62e-06	197	111	8	4847_DN
Drug	Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	MFSD9 UBOX5 TBC1D13 DLG1 CTNND2 HCFC1 TOP3A WDTC1	5.83e-06	198	111	8	7428_UP
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; PC3; HT_HG-U133A	SP100 REEP1 EDN1 LATS1 NBEAL2 GPR75 HCFC1 AFF4	6.05e-06	199	111	8	6686_UP
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	MAGI1 SKIL NBEAL2 NKTR MARK2 PLK4 AFF4 NPAT	6.05e-06	199	111	8	1484_DN
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A	CLIC4 SKIL EDN1 KMT2A PLK4 AFF4 NR1D2	1.73e-05	166	111	7	4327_UP
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	SRPRA MED1 UBOX5 LPIN1 KMT2A DLG1 NKTR	3.86e-05	188	111	7	4545_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ZSWIM8 SKIL GLI3 KMT2A DLG1 LIMCH1 WDTC1	4.41e-05	192	111	7	4110_DN
Drug	clozapine; Down 200; 10uM; HL60; HT_HG-U133A	REEP1 MYO7A DDX60 SIPA1L3 MFSD9 GRAMD1B DNASE2	4.41e-05	192	111	7	6188_DN
Drug	retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A	TBC1D13 ARAP3 NBEAL2 PC HCFC1 TOP3A RBM38	4.71e-05	194	111	7	1211_DN
Drug	yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA	UBAP1 MED1 JMJD1C CTNND2 PC HCFC1 TOP3A	4.71e-05	194	111	7	1119_UP
Drug	5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA	SIPA1L3 CLIC4 SRPRA LPIN1 PTPN13 LIMCH1 PLK4	4.71e-05	194	111	7	898_UP
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	REEP1 SIPA1L3 UBOX5 PPP3CC MARK2 TOP3A WDTC1	4.71e-05	194	111	7	6070_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	NRIP1 SIPA1L3 MED1 KMT2A NKTR NR1D2 SON	4.71e-05	194	111	7	4361_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	SP100 UBAP1 SKIL LPIN1 MARK2 CTNND2 NPAT	4.86e-05	195	111	7	1639_DN
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A	ZSWIM8 ARID4B TBC1D13 GLI3 KMT2A MARK2 RBM38	4.86e-05	195	111	7	5313_DN
Drug	Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A	IFT74 LPIN1 KMT2A CTNND2 PLK4 FAM131B AFF4	4.86e-05	195	111	7	7144_UP
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	IFT74 MFSD9 NUP214 FCHO1 TBC1D13 FAM53B HCFC1	5.02e-05	196	111	7	7181_DN
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; HL60; HT_HG-U133A	MAGI1 SIPA1L3 LATS1 GLI3 LIMCH1 MLPH IMPG2	5.02e-05	196	111	7	2915_UP
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A	COL5A2 MFSD9 SRPRA DARS2 LIMCH1 WDTC1 NPAT	5.02e-05	196	111	7	6585_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	REEP1 LPIN1 KIF13A PLK4 HCFC1 TOP3A WDTC1	5.02e-05	196	111	7	2315_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; HL60; HT_HG-U133A	REEP1 UBOX5 GRAMD1B TBC1D13 KMT2A NKTR PLK4	5.02e-05	196	111	7	1865_UP
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	SP100 SKIL UBOX5 LPIN1 CTNND2 PLK4 AFF4	5.19e-05	197	111	7	3319_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MAGI1 SIPA1L3 MFSD9 FCHO1 LIMCH1 MARK2 PC	5.19e-05	197	111	7	6773_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	IFT74 RBM48 JMJD1C NBEAL2 PC HCFC1 NR1D2	5.19e-05	197	111	7	6230_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; HL60; HG-U133A	SP100 SRPRA UBOX5 FAM53B PLK4 DNASE2 NPAT	5.19e-05	197	111	7	1394_DN
Drug	Colistin sulfate [1264-72-8]; Down 200; 3uM; PC3; HT_HG-U133A	REEP1 DDX60 LPIN1 NBEAL2 FAM53B LIMCH1 AFF4	5.19e-05	197	111	7	4212_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A	REEP1 UBOX5 KMT2A KIF13A HCFC1 TOP3A WDTC1	5.19e-05	197	111	7	2772_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SP100 IFT74 SRPRA DLG1 FAM53B PLK4 NPAT	5.19e-05	197	111	7	5337_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; HL60; HG-U133A	REEP1 MFSD9 UBOX5 TBC1D13 SAG GLI3 WDTC1	5.36e-05	198	111	7	1423_UP
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A	MYO7A LATS1 GLI3 KIF13A PLK4 DNASE2 AFF4	5.36e-05	198	111	7	2725_UP
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A	NUP214 SKIL EDN1 NBEAL2 CTNND2 TOP3A AFF4	5.36e-05	198	111	7	4661_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	NBEAL2 PACS2 FAM53B MARK2 PLK4 HCFC1 NPAT	5.36e-05	198	111	7	5325_DN
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; PC3; HT_HG-U133A	SP100 UBAP1 PPP3CC FAM53B NKTR HCFC1 RBM38	5.53e-05	199	111	7	7262_DN
Drug	Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A	SP100 SIPA1L3 SKIL NKTR LIMCH1 CTNND2 AFF4	5.53e-05	199	111	7	5502_DN
Drug	Stachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A	SP100 UBOX5 JMJD1C KMT2A NKTR HCFC1 NPAT	5.53e-05	199	111	7	1751_DN
Drug	3-(1H-pyrrole-2-carboxylate	ETFA NUP214 EDN1 CACNA2D4 PPP3CC PKN3 WDTC1	1.48e-04	233	111	7	CID000005114
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	SKIL EDN1 KMT2A PLK4 AFF4 SON	1.55e-04	164	111	6	3852_UP
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	COL5A2 DDX60 UBAP1 SRPRA UBOX5 LPIN1	1.65e-04	166	111	6	6780_UP
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	UBAP1 MED1 SKIL MARK2 HCFC1 SON	2.13e-04	174	111	6	1302_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NRIP1 MED1 KMT2A NKTR NR1D2 SON	2.34e-04	177	111	6	985_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	NRIP1 MED1 KMT2A NKTR NR1D2 SON	2.41e-04	178	111	6	3998_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	NRIP1 MED1 KMT2A NKTR NR1D2 SON	2.48e-04	179	111	6	4585_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	NRIP1 ARID4B JMJD1C GRAMD1B GLI3 NPAT	2.56e-04	180	111	6	4541_DN
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NRIP1 SP100 KMT2A DLG1 FAM53B NR1D2	2.80e-04	183	111	6	1709_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NRIP1 ARID4B JMJD1C KANK1 PLK4 NPAT	2.88e-04	184	111	6	2321_DN
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A	NRIP1 ARID4B JMJD1C GLI3 SON NPAT	2.88e-04	184	111	6	4610_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	SIPA1L3 MED1 GLI3 NBEAL2 HCFC1 WDTC1	2.97e-04	185	111	6	6931_UP
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	NRIP1 MED1 DLG1 NKTR NR1D2 SON	2.97e-04	185	111	6	1673_DN
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A	SP100 UBOX5 KMT2A PLK4 TOP3A AFF4	3.42e-04	190	111	6	3848_UP
Drug	geranylgeranylacetone	EDN1 DLG1	3.49e-04	6	111	2	ctd:C031049
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA	COL5A2 LPIN1 KMT2A LIMCH1 PLK4 WDTC1	3.52e-04	191	111	6	994_UP
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A	ZSWIM8 REEP1 SIPA1L3 PPP3CC NKTR WDTC1	3.62e-04	192	111	6	2947_DN
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A	MFSD9 SRPRA DNASE2 NR1D2 WDTC1 NPAT	3.62e-04	192	111	6	3245_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; PC3; HT_HG-U133A	SP100 REEP1 IFT74 DDX60 NUP214 PLK4	3.62e-04	192	111	6	7382_UP
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SPAG1 ARID4B RBM48 SKIL NKTR HCFC1	3.72e-04	193	111	6	4846_DN
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	NRIP1 REEP1 MED1 KMT2A PLK4 SON	3.72e-04	193	111	6	3906_DN
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A	MYO7A DDX60 PEX5L LPIN1 KMT2A LIMCH1	3.72e-04	193	111	6	5437_UP
Drug	Gabapentin [60142-96-3]; Up 200; 23.4uM; HL60; HT_HG-U133A	COL5A2 SIPA1L3 UBOX5 GLI3 HHIPL2 DNASE2	3.72e-04	193	111	6	2731_UP
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	DDX60 FCHO1 TBC1D13 NBEAL2 KMT2A FAM53B	3.82e-04	194	111	6	1804_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	REEP1 MED1 SKIL DLG1 CTNND2 KIF13A	3.82e-04	194	111	6	3377_DN
Drug	Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SIPA1L3 NUP214 PEX5L KMT2A MARK2 WDTC1	3.82e-04	194	111	6	3301_UP
Drug	CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A	SP100 SIPA1L3 MFSD9 TBC1D13 WDTC1 NPAT	3.82e-04	194	111	6	7558_DN
Drug	Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ZSWIM8 SKIL PLK4 DNASE2 TOP3A NPAT	3.93e-04	195	111	6	5315_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	SIPA1L3 RBM48 UBOX5 NBEAL2 FAM53B HCFC1	3.93e-04	195	111	6	4533_DN
Drug	Tribenoside [10310-32-4]; Down 200; 8.4uM; HL60; HT_HG-U133A	SRPRA KANK1 FAM53B HCFC1 TOP3A WDTC1	3.93e-04	195	111	6	2946_DN
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	REEP1 RBM48 SKIL UBOX5 DLG1 TOP3A	3.93e-04	195	111	6	3330_DN
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A	SP100 SIPA1L3 MFSD9 SRPRA LPIN1 TOP3A	3.93e-04	195	111	6	6654_DN
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A	IFT74 GRAMD1B ARAP3 PPP3CC MARK2 HCFC1	3.93e-04	195	111	6	2956_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZSWIM8 IFT74 MED1 SKIL PLK4 WDTC1	3.93e-04	195	111	6	6979_DN
Drug	5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA	SP100 SRPRA UBOX5 GLI3 LIMCH1 PLK4	3.93e-04	195	111	6	903_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	SIPA1L3 UBAP1 MED1 EDN1 KMT2A NR1D2	3.93e-04	195	111	6	2071_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	UBAP1 SKIL KMT2A CTNND2 TOP3A AFF4	3.93e-04	195	111	6	953_DN
Drug	Troleandomycin [2751-09-9]; Down 200; 5uM; MCF7; HT_HG-U133A	SIPA1L3 UBAP1 SRPRA LPIN1 NKTR PLK4	4.04e-04	196	111	6	1465_DN
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	SIPA1L3 UBAP1 SKIL LPIN1 DLG1 NKTR	4.04e-04	196	111	6	2511_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	REEP1 RBM48 TBC1D13 PTPN13 NBEAL2 WDTC1	4.04e-04	196	111	6	7228_DN
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A	IFT74 FCHO1 KMT2A PACS2 FAM53B HCFC1	4.04e-04	196	111	6	1294_DN
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SPAG1 RBM48 NKTR CTNND2 PLK4 NR1D2	4.04e-04	196	111	6	7425_UP
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A	MAGI1 SRPRA UBOX5 NKTR LIMCH1 WDTC1	4.04e-04	196	111	6	4728_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A	SP100 UBAP1 CLIC4 SRPRA KMT2A SON	4.04e-04	196	111	6	1567_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; PC3; HT_HG-U133A	CLIC4 EDN1 LPIN1 NBEAL2 KMT2A PLK4	4.04e-04	196	111	6	4319_UP
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; HL60; HT_HG-U133A	IFT74 DDX60 FCHO1 ARAP3 NR1D2 WDTC1	4.04e-04	196	111	6	2551_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A	IFT74 SIPA1L3 MED1 RRP9 GLI3 PLK4	4.04e-04	196	111	6	2829_DN
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A	COL5A2 REEP1 UBOX5 LPIN1 PLK4 FAM131B	4.15e-04	197	111	6	2455_UP
Drug	R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A	ARID4B SRPRA KNOP1 DLG1 MARK2 SON	4.15e-04	197	111	6	164_DN
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	COL5A2 SP100 UBOX5 LIMCH1 PLK4 WDTC1	4.15e-04	197	111	6	7217_UP
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A	MAGI1 SP100 SIPA1L3 NUP214 UBOX5 LIMCH1	4.15e-04	197	111	6	3549_DN
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	REEP1 KMT2A FAM53B NKTR TOP3A WDTC1	4.15e-04	197	111	6	7431_DN
Drug	Etomidate [33125-97-2]; Down 200; 16.4uM; HL60; HT_HG-U133A	IFT74 MFSD9 PPP3CC FAM53B HCFC1 WDTC1	4.15e-04	197	111	6	2958_DN
Drug	CP-863187 [668981-07-5]; Down 200; 10uM; MCF7; HT_HG-U133A	MAGI1 REEP1 SIPA1L3 PPP3CC FAM53B PC	4.15e-04	197	111	6	7553_DN
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	IFT74 MED1 KIF13A PLK4 WDTC1 NPAT	4.15e-04	197	111	6	1676_UP
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	REEP1 IFT74 SIPA1L3 SKIL UBOX5 WDTC1	4.15e-04	197	111	6	3256_DN
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SP100 REEP1 SIPA1L3 UBOX5 LPIN1 NKTR	4.15e-04	197	111	6	1529_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	SIPA1L3 UBOX5 FAM53B PLK4 HCFC1 WDTC1	4.15e-04	197	111	6	7342_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	RBM48 SKIL GLI3 KMT2A HCFC1 TOP3A	4.15e-04	197	111	6	3406_DN
Disease	Adenoid Cystic Carcinoma	MAGI1 ARID4B JMJD1C MARK2 SON	3.12e-05	100	106	5	C0010606
Disease	reading and spelling ability	NRIP1 MMADHC ZNF385D PTPN13 SRGAP3	3.40e-04	166	106	5	EFO_0005301
Disease	benign neoplasm (implicated_via_orthology)	LATS1 DLG1	3.53e-04	8	106	2	DOID:0060072 (implicated_via_orthology)
Disease	Disorders of Intracellular Cobalamin Metabolism	MMADHC HCFC1	5.65e-04	10	106	2	cv:CN043592
Disease	Diverticular Bleeding	ETFA GPR158	9.72e-04	13	106	2	C4505353
Disease	Diverticular Diseases	ETFA GPR158	9.72e-04	13	106	2	C4317009
Disease	Disorder of eye	MYO7A PCARE CACNA2D4 SAG IMPG2	1.03e-03	212	106	5	C0015397
Disease	mean platelet volume	COL6A6 DOCK11 CLIC4 SIN3A CWC22 JMJD1C GRAMD1B ACSL3 MCM9 FAM53B RBM38	1.11e-03	1020	106	11	EFO_0004584
Disease	corneal resistance factor	CEP170 PTPN13 GPR158 GLI3 KMT2A FAM53B MLPH	1.24e-03	451	106	7	EFO_0010067
Disease	Night blindness, congenital stationary	CACNA2D4 SAG	1.68e-03	17	106	2	C0339535
Disease	serum gamma-glutamyl transferase measurement	SGSM1 DOCK11 SIPA1L3 HECTD4 FCHO1 JMJD1C NBEAL2 KMT2A FAM53B PKN3	1.69e-03	914	106	10	EFO_0004532
Disease	Microcephaly	NUP214 SIN3A PLK4	1.83e-03	67	106	3	C0025958
Disease	congenital heart disease (implicated_via_orthology)	KMT2A HCFC1 SON	1.99e-03	69	106	3	DOID:1682 (implicated_via_orthology)
Disease	Retinitis pigmentosa	PCARE SAG IMPG2	2.43e-03	74	106	3	cv:C0035334
Disease	hemoglobin change measurement	MAGI1 KMT2A	2.82e-03	22	106	2	EFO_0600027
Disease	serum IgG glycosylation measurement	MAGI1 IFT74 ZNF385D USF3 GPR158 GLI3 PRICKLE2	2.85e-03	523	106	7	EFO_0005193
Disease	cancer (implicated_via_orthology)	SIN3A KANK1 LATS1 FRMD6 DLG1	2.86e-03	268	106	5	DOID:162 (implicated_via_orthology)
Disease	alcohol drinking	HECTD4 CTNND2 RBM38	3.14e-03	81	106	3	EFO_0004329

Protein segments in the cluster

Peptide	Gene	Start	Entry
TKHKTMLEARNGSGT	ZNF385D	226	Q9H6B1
GMKSHSTKSPARTQS	ARID4B	1176	Q4LE39
AGSAMPTSSSFKHRI	CEP170	1271	Q5SW79
KLSPKHPESNTAGMD	CLIC4	106	Q9Y696
SSKSNGLSKDMEALH	AGAP11	196	Q8TF27
HSSSDLARQKFGTMP	ARAP3	1336	Q8WWN8
HSKNTPLAMSDVGKV	CRYBG3	1511	Q68DQ2
PDDMGSKGLKHVTSN	DLG1	671	Q12959
DNMSSAVPNHSPEKK	ARFGAP2	136	Q8N6H7
MAASGKTSKSEPNHV	SAG	1	P10523
KSDGHLSFLKPDMSS	CASP8AP2	1451	Q9UKL3
KTASQVHLMKFSPDG	DMXL1	166	Q9Y485
GAKGEHTSRKDAMTA	CTNND2	1101	Q9UQB3
MVEKGSDHSSDKSPS	GRAMD1B	41	Q3KR37
GNSMTELKPSSKAHL	AFF4	281	Q9UHB7
RSHSGKVEMKANNFP	CPXCR1	111	Q8N123
PGAMHGSQKDTTFTK	RBM38	21	Q9H0Z9
APDSSKDGRNHHKTM	RBM48	221	Q5RL73
KGHTRNKSTSSAMSG	RAB3IP	281	Q96QF0
TATDKGTPSMSGHCK	PCDHA2	321	Q9Y5H9
AQEKKAHASLMSPGR	NPAT	196	Q14207
AHASLMSPGRRKSES	NPAT	201	Q14207
TMKRHSSRDAAGKPQ	FCHO1	396	O14526
DSSGTKPANKRPMSS	HCFC1	2006	P51610
TNATPDSHIMKKLSG	MMADHC	281	Q9H3L0
SAVSSTGDPMHNKRS	GLI3	421	P10071
GRASKMPAASKSSSD	M1AP	501	Q8TC57
SPASHSSKTGKVNGM	MAGI1	591	Q96QZ7
GSSKPDMEKSHFTRD	MAGI3	386	Q5TCQ9
PKIHNEMASTSDKGA	LRIF1	531	Q5T3J3
MSLNKRHSSGDGNSK	MFSD9	456	Q8NBP5
LSKPSDAAKAEHNMS	LATS1	41	O95835
SSEKKTGHPRTSMLQ	GPR158	886	Q5T848
KMDPNVSDSKHSIAN	JMJD1C	536	Q15652
MKSSVAQIKPSSGHD	CWC22	1	Q9HCG8
MAPRKGSSRVAKTNS	CDCA8	1	Q53HL2
QPTRKGSKHFSQDVM	DDX60	1466	Q8IY21
TFSRELHTPKKMSQG	FAM53B	21	Q14153
KKHSGSGENTNRAMS	OR4M1	226	Q8NGD0
RNTKGHPMAERKSSS	PEX5L	186	Q8IYB4
MAHTTKVNGSASGKA	KANK1	1	Q14678
GELPQAAKSSSPHKM	LPIN1	276	Q14693
SNHSMDLTKSKDPPG	NRIP1	596	P48552
DSTMLATKTVKHGAP	NUP214	1066	P35658
NKKSPLAMSHASGVK	KNOP1	116	Q1ED39
HEDSTMQAGPKAKST	PACS2	181	Q86VP3
ASLNEKTPKGHSVFM	HECTD4	31	Q9Y4D8
MSSDEKGISPAHKTS	OSBPL6	1	Q9BZF3
SKESMVSPKISAGHQ	GPR75	451	O95800
AKSSFSGISRSMKDH	FAM131B	56	Q86XD5
QPRSNHSLDTDKMAS	OR8J2	261	Q8NGG1
FSNPKRSSSLAMTGH	PRICKLE2	446	Q7Z3G6
SRASGSSAGSMKHKR	FRMD6	366	Q96NE9
SSKLNQARSMSGHPE	CKAP5	1461	Q14008
MASNHKSSAARPVSR	IFT74	1	Q96LB3
QPSKAQDSSMRGHTK	DNASE2	101	O00115
SKHFGIDRKSQTMPA	DOCK11	1341	Q5JSL3
AMPVFSKKNETRSHG	CACNA2D4	511	Q7Z3S7
TMRSPDGSKKHPART	COL5A2	1281	P05997
LGHLDSKPSSKSNMI	MARK2	21	Q7KZI7
KNSHLDGSSSSEMKQ	KMT2A	2276	Q03164
ARAKSSMGSKALSHD	KIAA1210	216	Q9ULL0
KSLKSHSGRMRPSAE	HHIPL2	701	Q6UWX4
TMRNSVKSSFHDPKL	EDN1	181	P05305
ERRTANPNHDMSGSK	C18orf21	141	Q32NC0
SHTFKNGRMIESAPK	COL6A6	2246	A6NMZ7
NARKGMASHTFAKPV	MLPH	581	Q9BV36
HGLSSGSSSTKMKPQ	MED1	1161	Q15648
KKDDMSARRTSHGEP	LIMCH1	246	Q9UPQ0
TKQKMRTGSLPHSSE	MTBP	571	Q96DY7
TSSGQKSMHESKTSR	MTBP	806	Q96DY7
GKPSHQMSRSDAESL	PTPN13	1001	Q12923
SQSHMAKDIPFKTQG	PCARE	106	A6NGG8
NMTHTCASGTPKERK	PKN3	126	Q6P5Z2
SSAPGMTKSHSGVTK	NR1D2	81	Q14995
NGSSMPVEHNSKREK	KIF13A	1511	Q9H1H9
VSPHPKTSGENMASK	MCM9	761	Q9NXL9
DPSMKAHIGAIKATS	TAS2R40	236	P59535
SEHTAKKMKATNEPS	UBOX5	396	O94941
KSFRGHDLMSNTPDS	DARS2	606	Q6PI48
DKSSSKDMNSPTDRH	SRGAP1	826	Q7Z6B7
SMRSGKRNQSKTDAP	SKIL	356	P12757
KHAMNPKGHSERSDT	NKTR	251	P30414
LRMPSASGKHKAVST	OR7G2	226	Q8NG99
SGAIQHLAGMKDSKT	ETFA	281	P13804
SKDPTMGSHKTQRLL	NBEAL2	2436	Q6ZNJ1
PSQDTDGTKATKMAH	SIPA1L3	101	O60292
NLKDSSMADASKHGG	SIN3A	446	Q96ST3
KHGQPKMSRSASESA	REEP1	181	Q9H902
THKLAFPSKMGLSSS	IMPG2	461	Q9BZV3
QPKSNHSLDTDKMAS	OR8U3	261	Q8NH85
DHPFMSRNSSTKSKD	PLK4	261	O00444
NEKHLALSSSKSMPG	SPTY2D1	271	Q68D10
ALGAKASMENQPHSK	ACSL3	261	O95573
KDSIHAGGPMKSVTS	PPP3CC	481	P48454
SAETSGRSNAMPHIK	TDP1	481	Q9NUW8
RKSMKQSPSAGVHTF	WDTC1	221	Q8N5D0
PEGDSKMSFSKTHST	UBAP1	96	Q9NZ09
PDKKALSEGHSMRST	SRGAP3	926	O43295
MSATAAARKRGKPAS	RRP9	1	O43818
HPAKEMISKQAGDSS	SPAG1	596	Q07617
KHGEKAPMTSRSTST	SP100	426	P23497
HGRGMEKSNKSTKSD	SRPRA	221	P08240
RSGVTNMSSPHKNSV	TBC1D13	176	Q9NVG8
VSLGDSNSHSMKKDP	TEX13C	411	A0A0J9YWL9
MVPLGDSNSHSLKKD	TEX13C	431	A0A0J9YWL9
HFAMAAAKSKDSTPN	USF3	901	Q68DE3
KRHSSGSMDDRPSLS	SGSM1	226	Q2NKQ1
RPRASSSDMGSTAKK	TOP3A	966	Q13472
LHGTFSAKMLSSEPK	TRMT6	266	Q9UJA5
KKHTGMASIDSSAPE	ZSWIM8	1136	A7E2V4
AMPHSSSAKLSRGDS	ZDHHC5	366	Q9C0B5
AHGKDHPTAATKMSR	PC	431	P11498
SAAMKDLSGKHPVSA	SON	2361	P18583
FPKGTDTTMLHKLNS	MYO7A	516	Q13402